Search Count: 15
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2024-10-02 Classification: CYTOKINE Ligands: A1IDT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2024-10-02 Classification: CYTOKINE Ligands: A1IDS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2020-09-30 Classification: TRANSFERASE Ligands: FGF, SO4 |
 |
Human Plasmakallikrein Protease Domain In Complex With Active Site Directed Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: GSH, DMS, PO4, GOL, MU8 |
 |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.17 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: SO4, DMS, NA, J7B |
 |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: NW2, SO4, DMS |
 |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: SO4, DMS, NW5 |
 |
Coagulation Factor Xi Protease Domain In Complex With Active Site Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.63 Å Release Date: 2020-07-08 Classification: HYDROLASE Ligands: NWE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.26 Å Release Date: 2020-07-01 Classification: HYDROLASE Ligands: QGS |
 |
Syk Catalytic Domain Complexed With A Potent Orally Bioavailable Thiazole Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2015-09-23 Classification: Transferase/Transferase inhibitor Ligands: 55M |
 |
Syk Catalytic Domain Complexed With A Potent And Orally Bioavailable Benzisothiazole Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2015-09-23 Classification: Transferase/Transferase inhibitor Ligands: 55Y |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-09-16 Classification: Transferase/transferase inhibitor Ligands: GOL, CL, 55U |
 |
Discovery Of Nvp-Cgm097 - A Highly Potent And Selective Mdm2 Inhibitor Undergoing Phase 1 Clinical Trials In P53Wt Tumors: Hdm2 (Mdm2) Complexed With Nvp-Cgm097
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2015-07-29 Classification: CELL CYCLE Ligands: 4T4, CL |
 |
Discovery Of Nvp-Cgm097 - A Highly Potent And Selective Mdm2 Inhibitor Undergoing Phase 1 Clinical Trials In P53Wt Tumors: Hdm2 (Mdm2) Complexed With Cpd2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2015-07-29 Classification: CELL CYCLE Ligands: 4TH, CL |
 |
Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3,5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2012-06-13 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 07J, SO4, GOL |